The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Piperacillin Sodium (CAS 59703-84-3) Market Research Report 2024
Synopsis
Piperacillin Sodium is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity.
The classification of Piperacillin Sodium includes Piperacillin Sodium and Piperacillin and Tazobactam. The proportion of Piperacillin and Tazobactam in 2019 is about 78%, and the proportion is in increasing trend from 2015 to 2020.
Piperacillin Sodium is widely used in Piperacillin Sodium Injection and Piperacillin Sodium Compound Injection. The most proportion of Piperacillin Sodium is used in Piperacillin Sodium Compound Injection and the proportion in 2019 is about 86%.
China is the largest supply country, it account about 47% of global production in 2019, India is the second largest country with 33% of global share.
Asia-Pacific is the largest consumption market, with a market share nearly 84% in 2019. Following Asia-Pacific, Europe is the second largest consumption market with the market share of 12%.
Qilu Pharmaceutical, Pfizer Healthcare, Fresenius Kabi AG, Aurobindo Pharma, Sandoz Inc, NCPC s, etc. are the leaders of the industry.
The global Piperacillin Sodium (CAS 59703-84-3) market was valued at US$ 204.7 million in 2019 and is expected to reach US$ 208.1 million by the end of 2026, growing at a CAGR of 0.9% during 2021-2026.
This report focuses on Piperacillin Sodium (CAS 59703-84-3) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Piperacillin Sodium (CAS 59703-84-3) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Piperacillin Sodium (CAS 59703-84-3) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Piperacillin
Piperacillin and Tazobactam
Segment by Application
Piperacillin Sodium Injection
Piperacillin Sodium Compound Injection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Qilu Pharmaceutical
Pfizer Healthcare
Fresenius Kabi AG
Aurobindo Pharma
Sandoz Inc
NCPC
REYOUNG
Yuhan Corporation
LKPC
Nectar Lifesciences
Sterile India
Suanfarma
Rajasthan Antibiotics
Piperacillin Sodium is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity.
The classification of Piperacillin Sodium includes Piperacillin Sodium and Piperacillin and Tazobactam. The proportion of Piperacillin and Tazobactam in 2019 is about 78%, and the proportion is in increasing trend from 2015 to 2020.
Piperacillin Sodium is widely used in Piperacillin Sodium Injection and Piperacillin Sodium Compound Injection. The most proportion of Piperacillin Sodium is used in Piperacillin Sodium Compound Injection and the proportion in 2019 is about 86%.
China is the largest supply country, it account about 47% of global production in 2019, India is the second largest country with 33% of global share.
Asia-Pacific is the largest consumption market, with a market share nearly 84% in 2019. Following Asia-Pacific, Europe is the second largest consumption market with the market share of 12%.
Qilu Pharmaceutical, Pfizer Healthcare, Fresenius Kabi AG, Aurobindo Pharma, Sandoz Inc, NCPC s, etc. are the leaders of the industry.
The global Piperacillin Sodium (CAS 59703-84-3) market was valued at US$ 204.7 million in 2019 and is expected to reach US$ 208.1 million by the end of 2026, growing at a CAGR of 0.9% during 2021-2026.
This report focuses on Piperacillin Sodium (CAS 59703-84-3) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Piperacillin Sodium (CAS 59703-84-3) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Piperacillin Sodium (CAS 59703-84-3) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Piperacillin
Piperacillin and Tazobactam
Segment by Application
Piperacillin Sodium Injection
Piperacillin Sodium Compound Injection
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Qilu Pharmaceutical
Pfizer Healthcare
Fresenius Kabi AG
Aurobindo Pharma
Sandoz Inc
NCPC
REYOUNG
Yuhan Corporation
LKPC
Nectar Lifesciences
Sterile India
Suanfarma
Rajasthan Antibiotics
Index1 Piperacillin Sodium (CAS 59703-84-3) Market Overview
1.1 Product Overview and Scope of Piperacillin Sodium (CAS 59703-84-3)
1.2 Piperacillin Sodium (CAS 59703-84-3) Segment by Type
1.2.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Piperacillin
1.2.3 Piperacillin and Tazobactam
1.3 Piperacillin Sodium (CAS 59703-84-3) Segment by Application
1.3.1 Piperacillin Sodium (CAS 59703-84-3) Sales Comparison by Application: (2021-2027)
1.3.2 Piperacillin Sodium Injection
1.3.3 Piperacillin Sodium Compound Injection
1.4 Global Piperacillin Sodium (CAS 59703-84-3) Market Size Estimates and Forecasts
1.4.1 Global Piperacillin Sodium (CAS 59703-84-3) Revenue 2016-2027
1.4.2 Global Piperacillin Sodium (CAS 59703-84-3) Sales 2016-2027
1.4.3 Piperacillin Sodium (CAS 59703-84-3) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Piperacillin Sodium (CAS 59703-84-3) Market Competition by Manufacturers
2.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Piperacillin Sodium (CAS 59703-84-3) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Piperacillin Sodium (CAS 59703-84-3) Manufacturing Sites, Area Served, Product Type
2.5 Piperacillin Sodium (CAS 59703-84-3) Market Competitive Situation and Trends
2.5.1 Piperacillin Sodium (CAS 59703-84-3) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Piperacillin Sodium (CAS 59703-84-3) Players Market Share by Revenue
2.5.3 Global Piperacillin Sodium (CAS 59703-84-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Piperacillin Sodium (CAS 59703-84-3) Retrospective Market Scenario by Region
3.1 Global Piperacillin Sodium (CAS 59703-84-3) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Piperacillin Sodium (CAS 59703-84-3) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures by Country
3.3.1 North America Piperacillin Sodium (CAS 59703-84-3) Sales by Country
3.3.2 North America Piperacillin Sodium (CAS 59703-84-3) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures by Country
3.4.1 Europe Piperacillin Sodium (CAS 59703-84-3) Sales by Country
3.4.2 Europe Piperacillin Sodium (CAS 59703-84-3) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures by Region
3.5.1 Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Sales by Region
3.5.2 Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures by Country
3.6.1 Latin America Piperacillin Sodium (CAS 59703-84-3) Sales by Country
3.6.2 Latin America Piperacillin Sodium (CAS 59703-84-3) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures by Country
3.7.1 Middle East and Africa Piperacillin Sodium (CAS 59703-84-3) Sales by Country
3.7.2 Middle East and Africa Piperacillin Sodium (CAS 59703-84-3) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Piperacillin Sodium (CAS 59703-84-3) Historic Market Analysis by Type
4.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
4.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Type (2016-2021)
4.3 Global Piperacillin Sodium (CAS 59703-84-3) Price by Type (2016-2021)
5 Global Piperacillin Sodium (CAS 59703-84-3) Historic Market Analysis by Application
5.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
5.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Application (2016-2021)
5.3 Global Piperacillin Sodium (CAS 59703-84-3) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Qilu Pharmaceutical
6.1.1 Qilu Pharmaceutical Corporation Information
6.1.2 Qilu Pharmaceutical Description and Business Overview
6.1.3 Qilu Pharmaceutical Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Qilu Pharmaceutical Product Portfolio
6.1.5 Qilu Pharmaceutical Recent Developments/Updates
6.2 Pfizer Healthcare
6.2.1 Pfizer Healthcare Corporation Information
6.2.2 Pfizer Healthcare Description and Business Overview
6.2.3 Pfizer Healthcare Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Healthcare Product Portfolio
6.2.5 Pfizer Healthcare Recent Developments/Updates
6.3 Fresenius Kabi AG
6.3.1 Fresenius Kabi AG Corporation Information
6.3.2 Fresenius Kabi AG Description and Business Overview
6.3.3 Fresenius Kabi AG Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Fresenius Kabi AG Product Portfolio
6.3.5 Fresenius Kabi AG Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Corporation Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aurobindo Pharma Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Sandoz Inc
6.5.1 Sandoz Inc Corporation Information
6.5.2 Sandoz Inc Description and Business Overview
6.5.3 Sandoz Inc Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sandoz Inc Product Portfolio
6.5.5 Sandoz Inc Recent Developments/Updates
6.6 NCPC
6.6.1 NCPC Corporation Information
6.6.2 NCPC Description and Business Overview
6.6.3 NCPC Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 NCPC Product Portfolio
6.6.5 NCPC Recent Developments/Updates
6.7 REYOUNG
6.6.1 REYOUNG Corporation Information
6.6.2 REYOUNG Description and Business Overview
6.6.3 REYOUNG Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 REYOUNG Product Portfolio
6.7.5 REYOUNG Recent Developments/Updates
6.8 Yuhan Corporation
6.8.1 Yuhan Corporation Corporation Information
6.8.2 Yuhan Corporation Description and Business Overview
6.8.3 Yuhan Corporation Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Yuhan Corporation Product Portfolio
6.8.5 Yuhan Corporation Recent Developments/Updates
6.9 LKPC
6.9.1 LKPC Corporation Information
6.9.2 LKPC Description and Business Overview
6.9.3 LKPC Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 LKPC Product Portfolio
6.9.5 LKPC Recent Developments/Updates
6.10 Nectar Lifesciences
6.10.1 Nectar Lifesciences Corporation Information
6.10.2 Nectar Lifesciences Description and Business Overview
6.10.3 Nectar Lifesciences Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Nectar Lifesciences Product Portfolio
6.10.5 Nectar Lifesciences Recent Developments/Updates
6.11 Sterile India
6.11.1 Sterile India Corporation Information
6.11.2 Sterile India Piperacillin Sodium (CAS 59703-84-3) Description and Business Overview
6.11.3 Sterile India Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Sterile India Product Portfolio
6.11.5 Sterile India Recent Developments/Updates
6.12 Suanfarma
6.12.1 Suanfarma Corporation Information
6.12.2 Suanfarma Piperacillin Sodium (CAS 59703-84-3) Description and Business Overview
6.12.3 Suanfarma Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Suanfarma Product Portfolio
6.12.5 Suanfarma Recent Developments/Updates
6.13 Rajasthan Antibiotics
6.13.1 Rajasthan Antibiotics Corporation Information
6.13.2 Rajasthan Antibiotics Piperacillin Sodium (CAS 59703-84-3) Description and Business Overview
6.13.3 Rajasthan Antibiotics Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Rajasthan Antibiotics Product Portfolio
6.13.5 Rajasthan Antibiotics Recent Developments/Updates
7 Piperacillin Sodium (CAS 59703-84-3) Manufacturing Cost Analysis
7.1 Piperacillin Sodium (CAS 59703-84-3) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Piperacillin Sodium (CAS 59703-84-3)
7.4 Piperacillin Sodium (CAS 59703-84-3) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Piperacillin Sodium (CAS 59703-84-3) Distributors List
8.3 Piperacillin Sodium (CAS 59703-84-3) Customers
9 Piperacillin Sodium (CAS 59703-84-3) Market Dynamics
9.1 Piperacillin Sodium (CAS 59703-84-3) Industry Trends
9.2 Piperacillin Sodium (CAS 59703-84-3) Growth Drivers
9.3 Piperacillin Sodium (CAS 59703-84-3) Market Challenges
9.4 Piperacillin Sodium (CAS 59703-84-3) Market Restraints
10 Global Market Forecast
10.1 Piperacillin Sodium (CAS 59703-84-3) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Piperacillin Sodium (CAS 59703-84-3) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Piperacillin Sodium (CAS 59703-84-3) by Type (2022-2027)
10.2 Piperacillin Sodium (CAS 59703-84-3) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Piperacillin Sodium (CAS 59703-84-3) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Piperacillin Sodium (CAS 59703-84-3) by Application (2022-2027)
10.3 Piperacillin Sodium (CAS 59703-84-3) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Piperacillin Sodium (CAS 59703-84-3) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Piperacillin Sodium (CAS 59703-84-3) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Piperacillin Sodium (CAS 59703-84-3) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Piperacillin Sodium (CAS 59703-84-3) Covered in This Study
Table 5. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Piperacillin Sodium (CAS 59703-84-3) Sales Share by Manufacturers (2016-2021)
Table 7. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Piperacillin Sodium (CAS 59703-84-3) Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Piperacillin Sodium (CAS 59703-84-3) Manufacturing Sites and Area Served
Table 11. Manufacturers Piperacillin Sodium (CAS 59703-84-3) Product Type
Table 12. Global Piperacillin Sodium (CAS 59703-84-3) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Piperacillin Sodium (CAS 59703-84-3) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piperacillin Sodium (CAS 59703-84-3) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Piperacillin Sodium (CAS 59703-84-3) Sales by Region (2016-2021) & (MT)
Table 16. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Region (2016-2021)
Table 17. Global Piperacillin Sodium (CAS 59703-84-3) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Piperacillin Sodium (CAS 59703-84-3) Sales by Country (2016-2021) & (MT)
Table 19. North America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Country (2016-2021)
Table 20. North America Piperacillin Sodium (CAS 59703-84-3) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Country (2016-2021)
Table 22. Europe Piperacillin Sodium (CAS 59703-84-3) Sales by Country (2016-2021) & (MT)
Table 23. Europe Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Country (2016-2021)
Table 24. Europe Piperacillin Sodium (CAS 59703-84-3) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Piperacillin Sodium (CAS 59703-84-3) Sales by Country (2016-2021) & (MT)
Table 31. Latin America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Country (2016-2021)
Table 32. Latin America Piperacillin Sodium (CAS 59703-84-3) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Piperacillin Sodium (CAS 59703-84-3) Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Piperacillin Sodium (CAS 59703-84-3) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Country (2016-2021)
Table 38. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Type (2016-2021)
Table 39. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
Table 40. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Type (2016-2021)
Table 42. Global Piperacillin Sodium (CAS 59703-84-3) Price (USD/Kg) by Type (2016-2021)
Table 43. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Application (2016-2021)
Table 44. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
Table 45. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Application (2016-2021)
Table 47. Global Piperacillin Sodium (CAS 59703-84-3) Price (USD/Kg) by Application (2016-2021)
Table 48. Qilu Pharmaceutical Corporation Information
Table 49. Qilu Pharmaceutical Description and Business Overview
Table 50. Qilu Pharmaceutical Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Qilu Pharmaceutical Piperacillin Sodium (CAS 59703-84-3) Product
Table 52. Qilu Pharmaceutical Recent Developments/Updates
Table 53. Pfizer Healthcare Corporation Information
Table 54. Pfizer Healthcare Description and Business Overview
Table 55. Pfizer Healthcare Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Pfizer Healthcare Piperacillin Sodium (CAS 59703-84-3) Product
Table 57. Pfizer Healthcare Recent Developments/Updates
Table 58. Fresenius Kabi AG Corporation Information
Table 59. Fresenius Kabi AG Description and Business Overview
Table 60. Fresenius Kabi AG Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Fresenius Kabi AG Piperacillin Sodium (CAS 59703-84-3) Product
Table 62. Fresenius Kabi AG Recent Developments/Updates
Table 63. Aurobindo Pharma Corporation Information
Table 64. Aurobindo Pharma Description and Business Overview
Table 65. Aurobindo Pharma Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Aurobindo Pharma Piperacillin Sodium (CAS 59703-84-3) Product
Table 67. Aurobindo Pharma Recent Developments/Updates
Table 68. Sandoz Inc Corporation Information
Table 69. Sandoz Inc Description and Business Overview
Table 70. Sandoz Inc Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Sandoz Inc Piperacillin Sodium (CAS 59703-84-3) Product
Table 72. Sandoz Inc Recent Developments/Updates
Table 73. NCPC Corporation Information
Table 74. NCPC Description and Business Overview
Table 75. NCPC Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. NCPC Piperacillin Sodium (CAS 59703-84-3) Product
Table 77. NCPC Recent Developments/Updates
Table 78. REYOUNG Corporation Information
Table 79. REYOUNG Description and Business Overview
Table 80. REYOUNG Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. REYOUNG Piperacillin Sodium (CAS 59703-84-3) Product
Table 82. REYOUNG Recent Developments/Updates
Table 83. Yuhan Corporation Corporation Information
Table 84. Yuhan Corporation Description and Business Overview
Table 85. Yuhan Corporation Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Yuhan Corporation Piperacillin Sodium (CAS 59703-84-3) Product
Table 87. Yuhan Corporation Recent Developments/Updates
Table 88. LKPC Corporation Information
Table 89. LKPC Description and Business Overview
Table 90. LKPC Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. LKPC Piperacillin Sodium (CAS 59703-84-3) Product
Table 92. LKPC Recent Developments/Updates
Table 93. Nectar Lifesciences Corporation Information
Table 94. Nectar Lifesciences Description and Business Overview
Table 95. Nectar Lifesciences Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Nectar Lifesciences Piperacillin Sodium (CAS 59703-84-3) Product
Table 97. Nectar Lifesciences Recent Developments/Updates
Table 98. Sterile India Corporation Information
Table 99. Sterile India Description and Business Overview
Table 100. Sterile India Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Sterile India Piperacillin Sodium (CAS 59703-84-3) Product
Table 102. Sterile India Recent Developments/Updates
Table 103. Suanfarma Corporation Information
Table 104. Suanfarma Description and Business Overview
Table 105. Suanfarma Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Suanfarma Piperacillin Sodium (CAS 59703-84-3) Product
Table 107. Suanfarma Recent Developments/Updates
Table 108. Rajasthan Antibiotics Corporation Information
Table 109. Rajasthan Antibiotics Description and Business Overview
Table 110. Rajasthan Antibiotics Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. Rajasthan Antibiotics Piperacillin Sodium (CAS 59703-84-3) Product
Table 112. Rajasthan Antibiotics Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Piperacillin Sodium (CAS 59703-84-3) Distributors List
Table 116. Piperacillin Sodium (CAS 59703-84-3) Customers List
Table 117. Piperacillin Sodium (CAS 59703-84-3) Market Trends
Table 118. Piperacillin Sodium (CAS 59703-84-3) Growth Drivers
Table 119. Piperacillin Sodium (CAS 59703-84-3) Market Restraints
Table 120. Global Piperacillin Sodium (CAS 59703-84-3) Sales Forecast by Type (2022-2027) & (MT)
Table 121. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Piperacillin Sodium (CAS 59703-84-3) Sales Forecast by Application (2022-2027) & (MT)
Table 125. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Piperacillin Sodium (CAS 59703-84-3) Sales Forecast by Region (2022-2027) & (MT)
Table 129. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Piperacillin Sodium (CAS 59703-84-3)
Figure 2. Global Piperacillin Sodium (CAS 59703-84-3) Market Share by Type in 2020 & 2027
Figure 3. Piperacillin Product Picture
Figure 4. Piperacillin and Tazobactam Product Picture
Figure 5. Global Piperacillin Sodium (CAS 59703-84-3) Market Share by Application in 2020 & 2027
Figure 6. Piperacillin Sodium Injection
Figure 7. Piperacillin Sodium Compound Injection
Figure 8. Global Piperacillin Sodium (CAS 59703-84-3) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Piperacillin Sodium (CAS 59703-84-3) Market Size 2016-2027 (US$ Million)
Figure 10. Global Piperacillin Sodium (CAS 59703-84-3) Sales 2016-2027 (MT)
Figure 11. Global Piperacillin Sodium (CAS 59703-84-3) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Piperacillin Sodium (CAS 59703-84-3) Sales Share by Manufacturers in 2020
Figure 13. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Piperacillin Sodium (CAS 59703-84-3) Players: Market Share by Revenue in 2020
Figure 15. Piperacillin Sodium (CAS 59703-84-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Region (2016-2021)
Figure 17. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Region in 2020
Figure 18. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Region (2016-2021)
Figure 19. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Region in 2020
Figure 20. U.S. Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Piperacillin Sodium (CAS 59703-84-3) by Type (2016-2021)
Figure 45. Sales Market Share of Piperacillin Sodium (CAS 59703-84-3) by Application (2016-2021)
Figure 46. Sales Market Share of Piperacillin Sodium (CAS 59703-84-3) by Application in 2020
Figure 47. Revenue Share of Piperacillin Sodium (CAS 59703-84-3) by Application (2016-2021)
Figure 48. Revenue Share of Piperacillin Sodium (CAS 59703-84-3) by Application in 2020
Figure 49. Manufacturing Cost Structure of Piperacillin Sodium (CAS 59703-84-3)
Figure 50. Manufacturing Process Analysis of Piperacillin Sodium (CAS 59703-84-3)
Figure 51. Piperacillin Sodium (CAS 59703-84-3) Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
